Format

Send to

Choose Destination
BMC Med. 2018 Nov 30;16(1):221. doi: 10.1186/s12916-018-1218-0.

Improving access to multi-drug resistant tuberculosis diagnostic and health services for refugees and migrants.

Author information

1
Division of Infection and Immunity, Centre for Clinical Microbiology, University College London, London, UK.
2
NIHR Biomedical Research Centre, University College London Hospitals NHS Foundation Trust, London, UK.
3
UCL Institute for Global Health, University College London, London, UK. i.abubakar@ucl.ac.uk.

Abstract

By the end of 2017, an estimated 68.5 million people were displaced from their homes worldwide, of whom 25.4 million were refugees. The transmission and globalization of multi-drug resistant tuberculosis during refugee migration is a now priority issue in the public health agenda. Political and scientific commitment at the highest national and international levels will be critical to intensifying action in promoting improved health services for migrants and refugees.

KEYWORDS:

Tuberculosis; migrants; multi-drug resistant; refugees

PMID:
30497477
PMCID:
PMC6267830
DOI:
10.1186/s12916-018-1218-0
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for BioMed Central Icon for PubMed Central
Loading ...
Support Center